by Legal Desire

19 June 2021

Herbert Smith Freehills Advises Sponsors On Carsgen Therapeutics’ HK$3.1 Billion Hong Kong IPO

Capital Markets & IPO Healthcare & Life Sciences Completed China Hong Kong United States

Advising firms

Herbert Smith Freehills

Underwriters acting for Goldman Sachs and UBS

Deal team

17 lawyers named

Lawyer	Firm	Seniority	Practice	Office
Matt Emsley Lead	Herbert Smith Freehills	Partner	Not stated	Hong Kong
Stanley Xie Lead	Herbert Smith Freehills Kewei	Partner	Not stated	Not stated
Siddhartha Sivaramakrishnan	Herbert Smith Freehills	Partner	Not stated	Singapore
George Wu	Herbert Smith Freehills	Of counsel	Not stated	Not stated
Maisie Ko	Herbert Smith Freehills	Senior associate	Not stated	Not stated
Echo Shen	Herbert Smith Freehills	Associate	Not stated	Not stated
Angela Yuen	Herbert Smith Freehills	Associate	Not stated	Not stated
Hilary Chong	Herbert Smith Freehills	Other	Not stated	Hong Kong
Sean Ji	Herbert Smith Freehills Kewei	Associate	Not stated	Not stated
Sunny Li	Herbert Smith Freehills	Other	Not stated	Sydney
Jasmin Tsang	Herbert Smith Freehills	Trainee	Not stated	Hong Kong
Alisha Chan	Herbert Smith Freehills	Other	Not stated	Not stated
Jessica Sun	Herbert Smith Freehills Kewei	Other	Not stated	Not stated
Lucy Yao	Herbert Smith Freehills Kewei	Other	Alternative Legal Services	Not stated
Helen Liang	Herbert Smith Freehills Kewei	Other	Not stated	Not stated
Selina Wang	Herbert Smith Freehills Kewei	Other	Not stated	Not stated
Shawna Peng	Herbert Smith Freehills Kewei	Other	Not stated	Not stated

Stated terms

Stated value: HKD 3.10bn (HK$3.1 billion)
What the figure measures: Issue size
Client: Not stated
Counterparties: CARsgen Therapeutics Holdings Limited (Issuer)
Goldman Sachs (Underwriters)
UBS (Underwriters)